IGC Pharma LLC
🇺🇸United States
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Clinical Trial on Agitation in Alzheimer's Dementia
Phase 2
Recruiting
- Conditions
- Alzheimer DiseaseAgitation,PsychomotorCare Giving BurdenNPSAggression
- Interventions
- Drug: IGC-AD1-ActiveDrug: IGC-AD1-Placebo
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- IGC Pharma, LLC
- Target Recruit Count
- 164
- Registration Number
- NCT05543681
- Locations
- 🇺🇸
Tekton Research LLC, Yukon, Oklahoma, United States
🇨🇦Island Health Authorities, Victoria, British Columbia, Canada
🇺🇸ClinCloud, LLC, Melbourne, Florida, United States
Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease
- First Posted Date
- 2021-02-11
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- IGC Pharma LLC
- Target Recruit Count
- 12
- Registration Number
- NCT04749563
- Locations
- 🇵🇷
Puerto Rico, San Juan, Puerto Rico
News
No news found